Search Courses

Course Catalog

Miscellaneous Courses
  • Course Code
    AVIR2021-1
    Available Until
    3/30/2023
    Course Type
    Annual Meeting
    CEUs
    1.00

    9:45a Presidential WelcomeRennie Mohabir, MBA, RT(R) (no CE)
    10:00a Evolution not Revolution - Indispensable CARE - Dr Janice Newsome, Shari Ulman Gold Medal Lecture Recipient, sponsored by Medtronic
    10:50a Complex Hemodialysis Access - Dr Mark Lessne
    11:40a Covid-19 - Dr Tania Bubb
    12:30p BREAK
    1:00p Prostate Artery Embolization - Dr Kavi Devulapalli
    2:00p PAD Inflow - Dr Kumar Madassery
    2:40p Medtronic Presentation (no CE)
    2:50p PE Interventions - Dr Charles Ritchie
    3:45p Combating Burnout - Dr Agnes Solberg
    4:20p Radiation Safety - Dr Lawrence Dauer
    5:00p Business Meeting/Awards (no CE)

  • Course Code
    AVIR2021-10
    Available Until
    3/21/2023
    Course Type
    Annual Meeting
    CEUs
    1.00

    Day 2 - SUNDAY MARCH 21st
    10:00a    Endovascular Therapy for Infrapopliteal Disease - Dr John Winscott
    11:00a    Medtronic Commercial (No CE)    
    11:10a    Global Health Panel Talk - Drs Azza, Laage-Gaupp, Dixon, Newsome, Mbuguje, Rukundo
    12:00p    Venous Interventions, SVC Occlusions - Dr Gail Peters
    12:30p    Dialysis Access Interventions - Dr Peter Bream
    1:10p    BREAK    
    1:30p    Stroke    Dr David Miller
    2:30p    Intracranial Aneurysms - Dr Rabih Tawk
    3:05p    Management of Carotid Disease - Dr Rabih Tawk
    4:00p    Y90 Radioembolization: Technique and Outcomes - Dr Ahmed Kamel Abdelaal
    4:45p    IR Social Media: What, Where, When and Why - Dr AJ Gunn
    5:15p    Portal Vein Thrombectomy - Dr Alex Wallace

  • Course Code
    AVIR2021-11
    Available Until
    3/21/2023
    Course Type
    Annual Meeting
    CEUs
    0.50

    Day 2 - SUNDAY MARCH 21st
    10:00a    Endovascular Therapy for Infrapopliteal Disease - Dr John Winscott
    11:00a    Medtronic Commercial (No CE)    
    11:10a    Global Health Panel Talk - Drs Azza, Laage-Gaupp, Dixon, Newsome, Mbuguje, Rukundo
    12:00p    Venous Interventions, SVC Occlusions - Dr Gail Peters
    12:30p    Dialysis Access Interventions - Dr Peter Bream
    1:10p    BREAK    
    1:30p    Stroke    Dr David Miller
    2:30p    Intracranial Aneurysms - Dr Rabih Tawk
    3:05p    Management of Carotid Disease - Dr Rabih Tawk
    4:00p    Y90 Radioembolization: Technique and Outcomes - Dr Ahmed Kamel Abdelaal
    4:45p    IR Social Media: What, Where, When and Why - Dr AJ Gunn
    5:15p    Portal Vein Thrombectomy - Dr Alex Wallace

  • Course Code
    AVIR2021-12
    Available Until
    3/21/2023
    Course Type
    Annual Meeting
    CEUs
    0.50

    Day 2 - SUNDAY MARCH 21st
    10:00a    Endovascular Therapy for Infrapopliteal Disease - Dr John Winscott
    11:00a    Medtronic Commercial (No CE)    
    11:10a    Global Health Panel Talk - Drs Azza, Laage-Gaupp, Dixon, Newsome, Mbuguje, Rukundo
    12:00p    Venous Interventions, SVC Occlusions - Dr Gail Peters
    12:30p    Dialysis Access Interventions - Dr Peter Bream
    1:10p    BREAK    
    1:30p    Stroke    Dr David Miller
    2:30p    Intracranial Aneurysms - Dr Rabih Tawk
    3:05p    Management of Carotid Disease - Dr Rabih Tawk
    4:00p    Y90 Radioembolization: Technique and Outcomes - Dr Ahmed Kamel Abdelaal
    4:45p    IR Social Media: What, Where, When and Why - Dr AJ Gunn
    5:15p    Portal Vein Thrombectomy - Dr Alex Wallace

  • Course Code
    AVIR2021-13
    Available Until
    3/21/2023
    Course Type
    Annual Meeting
    CEUs
    1.00

    Day 2 - SUNDAY MARCH 21st
    10:00a    Endovascular Therapy for Infrapopliteal Disease - Dr John Winscott
    11:00a    Medtronic Commercial (No CE)    
    11:10a    Global Health Panel Talk - Drs Azza, Laage-Gaupp, Dixon, Newsome, Mbuguje, Rukundo
    12:00p    Venous Interventions, SVC Occlusions - Dr Gail Peters
    12:30p    Dialysis Access Interventions - Dr Peter Bream
    1:10p    BREAK    
    1:30p    Stroke - Dr David Miller
    2:30p    Intracranial Aneurysms - Dr Rabih Tawk
    3:05p    Management of Carotid Disease - Dr Rabih Tawk
    4:00p    Y90 Radioembolization: Technique and Outcomes - Dr Ahmed Kamel Abdelaal
    4:45p    IR Social Media: What, Where, When and Why - Dr AJ Gunn
    5:15p    Portal Vein Thrombectomy - Dr Alex Wallace

  • Course Code
    AVIR2021-14
    Available Until
    3/21/2023
    Course Type
    Annual Meeting
    CEUs
    0.50

    Day 2 - SUNDAY MARCH 21st
    10:00a    Endovascular Therapy for Infrapopliteal Disease - Dr John Winscott
    11:00a    Medtronic Commercial (No CE)    
    11:10a    Global Health Panel Talk - Drs Azza, Laage-Gaupp, Dixon, Newsome, Mbuguje, Rukundo
    12:00p    Venous Interventions, SVC Occlusions - Dr Gail Peters
    12:30p    Dialysis Access Interventions - Dr Peter Bream
    1:10p    BREAK    
    1:30p    Stroke    Dr David Miller
    2:30p    Intracranial Aneurysms - Dr Rabih Tawk
    3:05p    Management of Carotid Disease - Dr Rabih Tawk
    4:00p    Y90 Radioembolization: Technique and Outcomes - Dr Ahmed Kamel Abdelaal
    4:45p    IR Social Media: What, Where, When and Why - Dr AJ Gunn
    5:15p    Portal Vein Thrombectomy - Dr Alex Wallace

  • Course Code
    AVIR2021-15
    Available Until
    3/21/2023
    Course Type
    Annual Meeting
    CEUs
    1.00

    Day 2 - SUNDAY MARCH 21st
    10:00a    Endovascular Therapy for Infrapopliteal Disease - Dr John Winscott
    11:00a    Medtronic Commercial (No CE)    
    11:10a    Global Health Panel Talk - Drs Azza, Laage-Gaupp, Dixon, Newsome, Mbuguje, Rukundo
    12:00p    Venous Interventions, SVC Occlusions - Dr Gail Peters
    12:30p    Dialysis Access Interventions - Dr Peter Bream
    1:10p    BREAK    
    1:30p    Stroke    Dr David Miller
    2:30p    Intracranial Aneurysms - Dr Rabih Tawk
    3:05p    Management of Carotid Disease - Dr Rabih Tawk
    4:00p    Y90 Radioembolization: Technique and Outcomes - Dr Ahmed Kamel Abdelaal
    4:45p    IR Social Media: What, Where, When and Why - Dr AJ Gunn
    5:15p    Portal Vein Thrombectomy - Dr Alex Wallace

  • Course Code
    AVIR2021-16
    Available Until
    3/21/2023
    Course Type
    Annual Meeting
    CEUs
    0.50

    Day 2 - SUNDAY MARCH 21st
    10:00a    Endovascular Therapy for Infrapopliteal Disease - Dr John Winscott
    11:00a    Medtronic Commercial (No CE)    
    11:10a    Global Health Panel Talk - Drs Azza, Laage-Gaupp, Dixon, Newsome, Mbuguje, Rukundo
    12:00p    Venous Interventions, SVC Occlusions - Dr Gail Peters
    12:30p    Dialysis Access Interventions - Dr Peter Bream
    1:10p    BREAK    
    1:30p    Stroke    Dr David Miller
    2:30p    Intracranial Aneurysms - Dr Rabih Tawk
    3:05p    Management of Carotid Disease - Dr Rabih Tawk
    4:00p    Y90 Radioembolization: Technique and Outcomes - Dr Ahmed Kamel Abdelaal
    4:45p    IR Social Media: What, Where, When and Why - Dr AJ Gunn
    5:15p    Portal Vein Thrombectomy - Dr Alex Wallace

  • Course Code
    AVIR2021-17
    Available Until
    3/21/2023
    Course Type
    Annual Meeting
    CEUs
    0.50

    Day 2 - SUNDAY MARCH 21st
    10:00a    Endovascular Therapy for Infrapopliteal Disease - Dr John Winscott
    11:00a    Medtronic Commercial (No CE)    
    11:10a    Global Health Panel Talk - Drs Azza, Laage-Gaupp, Dixon, Newsome, Mbuguje, Rukundo
    12:00p    Venous Interventions, SVC Occlusions - Dr Gail Peters
    12:30p    Dialysis Access Interventions - Dr Peter Bream
    1:10p    BREAK    
    1:30p    Stroke    Dr David Miller
    2:30p    Intracranial Aneurysms - Dr Rabih Tawk
    3:05p    Management of Carotid Disease - Dr Rabih Tawk
    4:00p    Y90 Radioembolization: Technique and Outcomes - Dr Ahmed Kamel Abdelaal
    4:45p    IR Social Media: What, Where, When and Why - Dr AJ Gunn
    5:15p    Portal Vein Thrombectomy - Dr Alex Wallace

  • Course Code
    AVIR2021-18
    Available Until
    3/21/2023
    Course Type
    Annual Meeting
    CEUs
    0.50

    Day 2 - SUNDAY MARCH 21st
    10:00a    Endovascular Therapy for Infrapopliteal Disease - Dr John Winscott
    11:00a    Medtronic Commercial (No CE)    
    11:10a    Global Health Panel Talk - Drs Azza, Laage-Gaupp, Dixon, Newsome, Mbuguje, Rukundo
    12:00p    Venous Interventions, SVC Occlusions - Dr Gail Peters
    12:30p    Dialysis Access Interventions - Dr Peter Bream
    1:10p    BREAK    
    1:30p    Stroke    Dr David Miller
    2:30p    Intracranial Aneurysms - Dr Rabih Tawk
    3:05p    Management of Carotid Disease - Dr Rabih Tawk
    4:00p    Y90 Radioembolization: Technique and Outcomes - Dr Ahmed Kamel Abdelaal
    4:45p    IR Social Media: What, Where, When and Why - Dr AJ Gunn
    5:15p    Portal Vein Thrombectomy - Dr Alex Wallace

  • Course Code
    AVIR2021-19
    Available Until
    3/22/2023
    Course Type
    Annual Meeting
    CEUs
    1.00

    Day 3 - MONDAY MARCH 22nd
    10:00a    Trauma Intervention - Dr Barbara Hamilton
    10:50a    Passion Projects and Burnout - Dr Aaron Fritts
    11:20a    Thermal Ablations - Dr Charles Martin
    11:55a    Advanced IVCF Filter Retrieval - Dr Peter Stibbs
    1:20p    BREAK    
    1:30p    10,000 foot Perspective on Embolization - Dr Ziv Haskal
    2:15p    Innovations in Peds IR - Dr John Racadio
    2:55p    Renal Ablations - Dr Robert Dixon
    3:30p    Artificial Intelligence in the IR Lab - Dr Rajesh Shah
    4:20p    IR Coding - Jennifer Eklund RT(R)(CV)(M) CIRCC

  • Course Code
    AVIR2021-2
    Available Until
    3/20/2023
    Course Type
    Annual Meeting
    CEUs
    1.00

    Day 1 - March 20, 2021

    10:00a Evolution not Revolution - Indispensable CARE by Dr Janice Newsome - Shari Ulman Gold Medal Lecture Recipient, sponsored by Medtronic
    10:50a Complex Hemodialysis Access by Dr Mark Lessne
    11:40a Covid-19 by Dr Tania Bubb
    12:30p BREAK
    1:00p Prostate Artery Embolization by Dr Kavi Devulapalli
    2:00p PAD Inflow by Dr Kumar Madassery
    2:40p Medtronic Presentation (no CE
    2:50p PE Interventions by Dr Charles Ritchie
    3:45p Combating Burnout by Dr Agnes Solberg
    4:20p Radiation Safety by Dr Lawrence Dauer
    5:00p Business Meeting/Awards (no CE)

  • Course Code
    AVIR2021-20
    Available Until
    3/22/2023
    Course Type
    Annual Meeting
    CEUs
    0.50

    Day 3 - MONDAY MARCH 22nd
    10:00a    Trauma Intervention - Dr Barbara Hamilton
    10:50a    Passion Projects and Burnout - Dr Aaron Fritts
    11:20a    Thermal Ablations - Dr Charles Martin
    11:55a    Advanced IVCF Filter Retrieval - Dr Peter Stibbs
    1:20p    BREAK    
    1:30p    10,000 foot Perspective on Embolization - Dr Ziv Haskal
    2:15p    Innovations in Peds IR - Dr John Racadio
    2:55p    Renal Ablations - Dr Robert Dixon
    3:30p    Artificial Intelligence in the IR Lab - Dr Rajesh Shah
    4:20p    IR Coding - Jennifer Eklund RT(R)(CV)(M) CIRCC

  • Course Code
    AVIR2021-21
    Available Until
    3/22/2023
    Course Type
    Annual Meeting
    CEUs
    0.50

    Day 3 - MONDAY MARCH 22nd
    10:00a    Trauma Intervention - Dr Barbara Hamilton
    10:50a    Passion Projects and Burnout - Dr Aaron Fritts
    11:20a    Thermal Ablations - Dr Charles Martin
    11:55a    Advanced IVCF Filter Retrieval - Dr Peter Stibbs
    1:20p    BREAK    
    1:30p    10,000 foot Perspective on Embolization - Dr Ziv Haskal
    2:15p    Innovations in Peds IR - Dr John Racadio
    2:55p    Renal Ablations - Dr Robert Dixon
    3:30p    Artificial Intelligence in the IR Lab - Dr Rajesh Shah
    4:20p    IR Coding - Jennifer Eklund RT(R)(CV)(M) CIRCC

  • Course Code
    AVIR2021-22
    Available Until
    3/22/2023
    Course Type
    Annual Meeting
    CEUs
    1.00

    Day 3 - MONDAY MARCH 22nd
    10:00a    Trauma Intervention - Dr Barbara Hamilton
    10:50a    Passion Projects and Burnout - Dr Aaron Fritts
    11:20a    Thermal Ablations - Dr Charles Martin
    11:55a    Advanced IVCF Filter Retrieval - Dr Peter Stibbs
    1:20p    BREAK    
    1:30p    10,000 foot Perspective on Embolization - Dr Ziv Haskal
    2:15p    Innovations in Peds IR - Dr John Racadio
    2:55p    Renal Ablations - Dr Robert Dixon
    3:30p    Artificial Intelligence in the IR Lab - Dr Rajesh Shah
    4:20p    IR Coding - Jennifer Eklund RT(R)(CV)(M) CIRCC

  • Course Code
    AVIR2021-23
    Available Until
    3/22/2023
    Course Type
    Annual Meeting
    CEUs
    0.50

    Day 3 - MONDAY MARCH 22nd
    10:00a    Trauma Intervention - Dr Barbara Hamilton
    10:50a    Passion Projects and Burnout - Dr Aaron Fritts
    11:20a    Thermal Ablations - Dr Charles Martin
    11:55a    Advanced IVCF Filter Retrieval - Dr Peter Stibbs
    1:20p    BREAK    
    1:30p    10,000 foot Perspective on Embolization - Dr Ziv Haskal
    2:15p    Innovations in Peds IR - Dr John Racadio
    2:55p    Renal Ablations - Dr Robert Dixon
    3:30p    Artificial Intelligence in the IR Lab - Dr Rajesh Shah
    4:20p    IR Coding - Jennifer Eklund RT(R)(CV)(M) CIRCC

  • Course Code
    AVIR2021-24
    Available Until
    3/22/2023
    Course Type
    Annual Meeting
    CEUs
    0.50

    Day 3 - MONDAY MARCH 22nd
    10:00a    Trauma Intervention - Dr Barbara Hamilton
    10:50a    Passion Projects and Burnout - Dr Aaron Fritts
    11:20a    Thermal Ablations - Dr Charles Martin
    11:55a    Advanced IVCF Filter Retrieval - Dr Peter Stibbs
    1:20p    BREAK    
    1:30p    10,000 foot Perspective on Embolization - Dr Ziv Haskal
    2:15p    Innovations in Peds IR - Dr John Racadio
    2:55p    Renal Ablations - Dr Robert Dixon
    3:30p    Artificial Intelligence in the IR Lab - Dr Rajesh Shah
    4:20p    IR Coding - Jennifer Eklund RT(R)(CV)(M) CIRCC

  • Course Code
    AVIR2021-25
    Available Until
    3/22/2023
    Course Type
    Annual Meeting
    CEUs
    0.50

    Day 3 - MONDAY MARCH 22nd
    10:00a    Trauma Intervention - Dr Barbara Hamilton
    10:50a    Passion Projects and Burnout - Dr Aaron Fritts
    11:20a    Thermal Ablations - Dr Charles Martin
    11:55a    Advanced IVCF Filter Retrieval - Dr Peter Stibbs
    1:20p    BREAK    
    1:30p    10,000 foot Perspective on Embolization - Dr Ziv Haskal
    2:15p    Innovations in Peds IR - Dr John Racadio
    2:55p    Renal Ablations - Dr Robert Dixon
    3:30p    Artificial Intelligence in the IR Lab - Dr Rajesh Shah
    4:20p    IR Coding - Jennifer Eklund RT(R)(CV)(M) CIRCC

  • Course Code
    AVIR2021-26
    Available Until
    3/22/2023
    Course Type
    Annual Meeting
    CEUs
    1.00

    Day 3 - MONDAY MARCH 22nd
    10:00a    Trauma Intervention - Dr Barbara Hamilton
    10:50a    Passion Projects and Burnout - Dr Aaron Fritts
    11:20a    Thermal Ablations - Dr Charles Martin
    11:55a    Advanced IVCF Filter Retrieval - Dr Peter Stibbs
    1:20p    BREAK    
    1:30p    10,000 foot Perspective on Embolization - Dr Ziv Haskal
    2:15p    Innovations in Peds IR - Dr John Racadio
    2:55p    Renal Ablations - Dr Robert Dixon
    3:30p    Artificial Intelligence in the IR Lab - Dr Rajesh Shah
    4:20p    IR Coding - Jennifer Eklund RT(R)(CV)(M) CIRCC

  • Course Code
    AVIR2021-27
    Available Until
    3/22/2023
    Course Type
    Annual Meeting
    CEUs
    1.00

    Day 3 - MONDAY MARCH 22nd
    10:00a    Trauma Intervention - Dr Barbara Hamilton
    10:50a    Passion Projects and Burnout - Dr Aaron Fritts
    11:20a    Thermal Ablations - Dr Charles Martin
    11:55a    Advanced IVCF Filter Retrieval - Dr Peter Stibbs
    1:20p    BREAK    
    1:30p    10,000 foot Perspective on Embolization - Dr Ziv Haskal
    2:15p    Innovations in Peds IR - Dr John Racadio
    2:55p    Renal Ablations - Dr Robert Dixon
    3:30p    Artificial Intelligence in the IR Lab - Dr Rajesh Shah
    4:20p    IR Coding - Jennifer Eklund RT(R)(CV)(M) CIRCC

  • Course Code
    AVIR2021-3
    Available Until
    3/20/2023
    Course Type
    Annual Meeting
    CEUs
    1.00

    Day 1 - March 20, 2021

    10:00a Evolution not Revolution - Indispensable CARE by Dr Janice Newsome - Shari Ulman Gold Medal Lecture Recipient, sponsored by Medtronic
    10:50a Complex Hemodialysis Access by Dr Mark Lessne
    11:40a Covid-19 by Dr Tania Bubb
    12:30p BREAK
    1:00p Prostate Artery Embolization by Dr Kavi Devulapalli
    2:00p PAD Inflow by Dr Kumar Madassery
    2:40p Medtronic Presentation (no CE
    2:50p PE Interventions by Dr Charles Ritchie
    3:45p Combating Burnout by Dr Agnes Solberg
    4:20p Radiation Safety by Dr Lawrence Dauer
    5:00p Business Meeting/Awards (no CE)

  • Course Code
    AVIR2021-4
    Available Until
    3/20/2023
    Course Type
    Annual Meeting
    CEUs
    0.50

    Day 1 - March 20, 2021

    10:00a Evolution not Revolution - Indispensable CARE by Dr Janice Newsome - Shari Ulman Gold Medal Lecture Recipient, sponsored by Medtronic
    10:50a Complex Hemodialysis Access by Dr Mark Lessne
    11:40a Covid-19 by Dr Tania Bubb
    12:30p BREAK
    1:00p Prostate Artery Embolization by Dr Kavi Devulapalli
    2:00p PAD Inflow by Dr Kumar Madassery
    2:40p Medtronic Presentation (no CE)
    2:50p PE Interventions by Dr Charles Ritchie
    3:45p Combating Burnout by Dr Agnes Solberg
    4:20p Radiation Safety by Dr Lawrence Dauer
    5:00p Business Meeting/Awards (no CE)

  • Course Code
    AVIR2021-5
    Available Until
    3/20/2023
    Course Type
    Annual Meeting
    CEUs
    0.50

    Day 1 - March 20, 2021

    10:00a Evolution not Revolution - Indispensable CARE by Dr Janice Newsome - Shari Ulman Gold Medal Lecture Recipient, sponsored by Medtronic
    10:50a Complex Hemodialysis Access by Dr Mark Lessne
    11:40a Covid-19 by Dr Tania Bubb
    12:30p BREAK
    1:00p Prostate Artery Embolization by Dr Kavi Devulapalli
    2:00p PAD Inflow by Dr Kumar Madassery
    2:40p Medtronic Presentation (no CE
    2:50p PE Interventions by Dr Charles Ritchie
    3:45p Combating Burnout by Dr Agnes Solberg
    4:20p Radiation Safety by Dr Lawrence Dauer
    5:00p Business Meeting/Awards (no CE)

  • Course Code
    AVIR2021-6
    Available Until
    3/20/2023
    Course Type
    Annual Meeting
    CEUs
    1.00

    Day 1 - March 20, 2021

    10:00a Evolution not Revolution - Indispensable CARE by Dr Janice Newsome - Shari Ulman Gold Medal Lecture Recipient, sponsored by Medtronic
    10:50a Complex Hemodialysis Access by Dr Mark Lessne
    11:40a Covid-19 by Dr Tania Bubb
    12:30p BREAK
    1:00p Prostate Artery Embolization by Dr Kavi Devulapalli
    2:00p PAD Inflow by Dr Kumar Madassery
    2:40p Medtronic Presentation (no CE
    2:50p PE Interventions by Dr Charles Ritchie
    3:45p Combating Burnout by Dr Agnes Solberg
    4:20p Radiation Safety by Dr Lawrence Dauer
    5:00p Business Meeting/Awards (no CE)

  • Course Code
    AVIR2021-7
    Available Until
    3/20/2023
    Course Type
    Annual Meeting
    CEUs
    0.50

    Day 1 - March 20, 2021

    10:00a Evolution not Revolution - Indispensable CARE by Dr Janice Newsome - Shari Ulman Gold Medal Lecture Recipient, sponsored by Medtronic
    10:50a Complex Hemodialysis Access by Dr Mark Lessne
    11:40a Covid-19 by Dr Tania Bubb
    12:30p BREAK
    1:00p Prostate Artery Embolization by Dr Kavi Devulapalli
    2:00p PAD Inflow by Dr Kumar Madassery
    2:40p Medtronic Presentation (no CE
    2:50p PE Interventions by Dr Charles Ritchie
    3:45p Combating Burnout by Dr Agnes Solberg
    4:20p Radiation Safety by Dr Lawrence Dauer
    5:00p Business Meeting/Awards (no CE)

  • Course Code
    AVIR2021-8
    Available Until
    3/20/2023
    Course Type
    Annual Meeting
    CEUs
    0.50

    Day 1 - March 20, 2021

    10:00a Evolution not Revolution - Indispensable CARE by Dr Janice Newsome - Shari Ulman Gold Medal Lecture Recipient, sponsored by Medtronic
    10:50a Complex Hemodialysis Access by Dr Mark Lessne
    11:40a Covid-19 by Dr Tania Bubb
    12:30p BREAK
    1:00p Prostate Artery Embolization by Dr Kavi Devulapalli
    2:00p PAD Inflow by Dr Kumar Madassery
    2:40p Medtronic Presentation (no CE
    2:50p PE Interventions by Dr Charles Ritchie
    3:45p Combating Burnout by Dr Agnes Solberg
    4:20p Radiation Safety by Dr Lawrence Dauer
    5:00p Business Meeting/Awards (no CE)

  • Course Code
    AVIR2021-9
    Available Until
    3/21/2023
    Course Type
    Annual Meeting
    CEUs
    1.00

    Day 2 - SUNDAY MARCH 21st
    10:00a    Endovascular Therapy for Infrapopliteal Disease - Dr John Winscott
    11:00a    Medtronic Commercial (No CE)    
    11:10a    Global Health Panel Talk - Drs Azza, Laage-Gaupp, Dixon, Newsome, Mbuguje, Rukundo
    12:00p    Venous Interventions, SVC Occlusions - Dr Gail Peters
    12:30p    Dialysis Access Interventions - Dr Peter Bream
    1:10p    BREAK    
    1:30p    Stroke - Dr David Miller
    2:30p    Intracranial Aneurysms - Dr Rabih Tawk
    3:05p    Management of Carotid Disease - Dr Rabih Tawk
    4:00p    Y90 Radioembolization: Technique and Outcomes - Dr Ahmed Kamel Abdelaal
    4:45p    IR Social Media: What, Where, When and Why - Dr AJ Gunn
    5:15p    Portal Vein Thrombectomy - Dr Alex Wallace

Miscellaneous Courses
  • Course Code
    AVIR-DJR55
    Available Until
    6/1/2023
    Course Type
    Directed Journal Readings
    CEUs
    1.00

    Purpose: To compare the utility of low-dose versus standard cone-beam computed tomography (CT) angiography protocols in
    identifying nontarget embolization (NTE) during prostatic artery embolization (PAE).
    Materials and Methods: A prospective, single-center, Phase-1 study (NCT02592473) was conducted for lower urinary tract
    symptoms in benign prostatic hyperplasia. Prostate volume, international prostate symptom score (IPSS), quality of life score (QoL),
    International Index of Erectile Function (IIEF), peak flow rate, UCLA Prostate Cancer Index (UCLA-PCI), and postvoid residual were
    recorded at baseline and 1, 3, 6, 12, and 24-months after PAE. Six-second (standard protocol, n 1⁄4 29) or 5-second (low-dose protocol
    n 1⁄4 45) rotations were made. Images were selected and matched in pairs by areas of NTE and compared by readers using a binomial
    generalized estimating equation model. Procedural outcomes were analyzed using a linear mixed model.
    Results: Seventy-four cone-beam CT angiographies were performed in 21 patients. IPSS and QoL scores significantly improved (P
    <.05). There was no change in UCLA-PCI or IIEF scores. Dose area product of the low- and standard-dose protocol were 37,340.82
    mGy$cm2 ± 104.66 and 62,645.66 mGy$cm2 ± 12,711.48, respectively, representing a dose reduction of 40.4%. A total of 120

    comparisons showed no preference between the 2 protocols (P 1⁄4.24). Observers identified 76 and 69 instances of NTE in the standard-
    and low-dose protocols, respectively (P 1⁄4.125).

    Conclusions: Low-dose cone-beam CT angiography achieved equivalent clinical utility in identifying NTE during PAE, with the
    advantage of a lower radiation dose.

  • Course Code
    AVIR-DJR58
    Available Until
    11/1/2023
    Course Type
    Directed Journal Readings
    CEUs
    1.00

    Purpose: To compare patients treated with large-volume paracentesis (LVP), transjugular intrahepatic portosystemic shunt (TIPS), and
    peritoneovenous shunt (PVS) for ascites.
    Materials and Methods: A retrospective study of 192 patients treated with LVP (94), TIPS (75), or PVS (23) was performed.
    Records were reviewed for patient characteristics and outcomes. The patients’ age differed (LVP, 59.5 years; TIPS, 58.8 years; and PVS,
    65.6 years; P 1⁄4 .003). Nonalcoholic steatohepatitis was the most common etiology in the PVS cohort (11/23, 47%), and hepatitis C in
    the TIPS (27/75, 36%), and LVP cohorts (43/94, 46%) (P 1⁄4.032). The model for end-stage liver disease score was significantly different
    (LVP, 14; TIPS, 13; and PVS, 8; P 1⁄4 .035). Hepatocellular carcinoma was higher in the PVS cohort (6/23 patients, 25%) than in the
    TIPS (4/75, 5%), and LVP (12/94, 12%) cohorts (P 1⁄4 .03).
    Results: Emergency department visits and hospital readmissions were the highest in the LVP cohort (40%, 2 readmissions, P <
    .001). Patients required fewer LVPs after TIPS (1.5 to 0.14, P < .001) or PVS (2.1 to 0.5, P 1⁄4 .019). In an unadjusted Cox model,
    patients in the TIPS cohort were found to have a 58% reduction in the risk of death compared with patients in the LVP cohort (P 1⁄4.003).
    Transplant-free survival (PVS, 44 days; TIPS, 155 days; and LVP, 213 days) differed (log rank 1⁄4 0.001).
    Conclusions: The survival in the PVS and TIPS cohorts was similar, with less healthcare utilization than the LVP cohort. PVS is a
    satisfactory alternative to LVP.

  • Course Code
    AVIR-DJR59
    Available Until
    12/1/2023
    Course Type
    Directed Journal Readings
    CEUs
    1.00

    Purpose: This study sought to define thromboembolic risk and mortality in patients with heparin-induced thrombocytopenia (HIT)
    undergoing inferior vena cava filter (IVCF) placement, in light of the American Society of Hematology’s 2018 guidelines against routine
    use of IVCFs in this population.
    Methods: A total of 26 patients with HIT who received IVCFs were retrospectively reviewed, and the outcomes of this group were
    compared with those of 4,707 controls with either HIT or IVCFs alone and with reported outcomes in prior studies.
    Results: The patient group demonstrated 6- and 12-month mortality rates of 26.9% and 30.8%, respectively, which did not differ

    significantly from those of the control groups and were in line with published mortality rates in the literature. The measured throm-
    boembolic risk of 19.2% in the patient group was also within the range of published rates for patients with HIT or IVCF alone.

    Conclusions: IVCF placement did not significantly increase the risk of thromboembolism or death in patients with HIT and may be a
    viable option in the subset of these patients who are not candidates for anticoagulation.

  • Course Code
    AVIR-DJR60
    Available Until
    1/9/2023
    Course Type
    Directed Journal Readings
    CEUs
    1.00

    An abnormally invasive placenta is an increasing and potentially life-threatening pregnancy complication. The case presented herein is a
    heterotopic dichorial pregnancy with implantation of 1 placenta within the isthmocervical area, which caused vaginal bleeding during
    the 20th week of pregnancy, requiring a blood transfusion. To stop the bleeding, a bilateral embolization of the cervical branches of the
    uterine arteries was performed. The embolization was well tolerated and resulted in the abrupt and lasting cessation of bleeding for more
    than 10 weeks, resulting in the live birth of 1 child.

  • Course Code
    AVIR-DJR61
    Available Until
    1/8/2023
    Course Type
    Directed Journal Readings
    CEUs
    1.00

    Purpose: To analyze the impact of physician-specific equipment preference on cost variation for procedures typically performed by
    interventional radiologists at a tertiary care academic hospital.
    Materials and Methods: From October 2017 to October 2019, data on all expendable items used by 9 interventional radiologists for
    11 common interventional radiology procedure categories were compiled from the hospital analytics system. This search yielded a final
    dataset of 44,654 items used in 2,121 procedures of 11 different categories. The mean cost per case for each physician as well as the
    mean, standard deviation, and coefficient of variation (CV) of the mean cost per case across physicians were calculated. The proportion
    of spending by item type was compared across physicians for 2 high-variation, high-volume procedures. The relationship between the
    mean cost per case and case volume was examined using linear regression.
    Results: There was a high variability within each procedure, with the highest and the lowest CV for radioembolization administration
    (56.6%) and transjugular liver biopsy (4.9%), respectively. Variation in transarterial chemoembolization cost was mainly driven by
    microcatheters/microwires, while for nephrostomy, the main drivers were catheters/wires and access sets. Mean spending by physician
    was not significantly correlated with case volume (P 1⁄4.584).
    Conclusions: Physicians vary in their item selection even for standard procedures. While the financial impact of these differences vary
    across procedures, these findings suggest that standardization may offer an opportunity for cost savings.

  • Course Code
    AVIR-DJR62
    Available Until
    3/1/2024
    Course Type
    Directed Journal Readings
    CEUs
    1.00

    Purpose: To retrospectively assess the safety and efficacy of percutaneous arteriovenous fistula (PAVF) creation with the WavelinQ 4-F EndoAVF System. Materials and Methods: From February 2018 to June 2020, 30 PAVFs were created in 30 consecutive patients (men; age, 55.3 years = 13.6). Of the 30 patients, 21 (70%) were already on hemodialysis using a central venous catheter. The primary outcome measures were technical success, complications, and cannulation rate. The secondary outcome measures included the number of secondary procedures needed for cannulation, maintenance time to cannulation, and PAVF survival. Results: Technical success was 100%. The adverse event rate was 6.7% (2/30), including a pseudoaneurysm of the brachial artery that developed immediately after sheath removal and an aneurysm of the anastomosis 17 days after the procedure, which was treated with a covered stent placed in the arterial side. The mean follow-up was 547 days 315.7 (range, 14–1,071 days). The cannulation rate was 86.7% (26/30). The mean time to cannulation was 61.3 days = 32.5 (range, 15-135 days). The mean follow-up after cannulation was 566.2 days + 252.7 (range, 35–1,041 days). Four PAVFs were thrombosed after cannulation, with 2 of them successfully declotted. Sixteen interventions were needed to achieve can nulation after the index procedure in 15 patients (overall, 0.53 procedures/patient). Seven maintenance endovascular interventions (following cannulation) were performed during the follow-up period in 6 patients (overall, 0.27 procedures/ patient, 0.17 procedures/patient-years). For the PAVFs that were cannulated, patency was 96% at 1 year, and 82% at 2 and 3 years, according to the Kaplan-Meier survival analysis. Conclusions: This initial experience suggests that PAVF creation is safe and can be successfully performed with high maturation and long-term patency rates. Larger-scale prospective studies are needed to validate the results.

  • Course Code
    AVIR-DJR63
    Available Until
    3/1/2024
    Course Type
    Directed Journal Readings
    CEUs
    1.00

    Purpose: Although many studies have examined the efficiency of various protective devices for reducing the dose of
    radiation exposure to physicians during interventional pain procedures, no study has compared the protective effect of
    these devices when they are used in combination. The purpose of this prospective experimental study was to determine the
    best combination of radiation-shielding devices.

    Materials and Methods: Using anthropomorphic phantoms of a physician and patient, we measured the radiation pro-
    tection efficiency (RPE) of each of the following protection methods and in combination during C-arm–guided simulated

    lumbar epidural injection: (a) personal protective equipment (PPE), (b) bedside curtain shield (Curtain), (c) x-ray tube filter
    (Filter), and (d) fluoroscopic collimation method (Collimation). We measured exposure doses using personal electronic
    dosimeters at the eye, thyroid, and gonad levels for 1 minute. Each experiment was repeated 15 times.
    Results: The radiation exposure dose and RPE with the best single-, double-, and triple-protection methods were as
    follows: PPE for the single-protection method (11.82 μSv/min, 80.04%), PPE + Collimation for the double-combination
    method (4.68 μSv/min, 92.09%), and PPE + Collimation + Curtain for the triple-combination method (3.08 μSv/min,
    93.39%). Additionally, PPE + Collimation + Curtain + Filter for the quadruple-combination method resulted in a radiation
    exposure and RPE of 2.91 μSv/min and 93.61%, respectively, compared with nonprotection.

    Conclusions: The best single-, double-, and triple-protection method was PPE, PPE + Collimation, and PPE + Collima-
    tion + Curtain, respectively. While preparing protective equipment, we recommend prioritizing equipment in this order.

  • Course Code
    AVIR-DJR64
    Available Until
    9/20/2024
    Course Type
    Directed Journal Readings
    CEUs
    1.00

    Purpose: To evaluate the feasibility and technical outcomes of retrograde access via occluded pedal arteries in endovascular treatment
    of critical limb ischemia (CLI) when the conventional antegrade approach fails.
    Materials and Methods: One hundred fifty-one patients with CLI (age 69 y ± 10.5; 116 men) who were not surgical candidates and
    were treated via retrograde pedal access between January 2016 and January 2018 were evaluated retrospectively. Seventy patients in
    whom retrograde access was performed through occluded arteries constituted the occluded group, and 81 patients who were treated via
    retrograde access from patent arteries constituted the nonoccluded group. Pedal access success, lesion crossing success, angiographic
    success, overall technical success, and procedure-related complications were evaluated and compared between groups.
    Results: Pedal access success (74 of 78 vs 83 of 87 attempts; P 1⁄4.873) and lesion crossing success (64 of 78 vs 77 of 87 lesions; P 1⁄4
    .340) were comparable between subgroups. Angiographic success (54 of 78 vs 77 of 87 lesions; P 1⁄4.012) and overall technical success
    (48 of 70 vs 72 of 81 patients; P 1⁄4 .004) rates were lower in the occluded group. Procedure-related complications were similar between
    groups (P 1⁄4 .096).

    Conclusions: Retrograde pedal access from occluded pedal arteries is a feasible option when an antegrade approach fails in endo-
    vascular treatment of CLI. Although it has lower technical success, its use enables angiosome-directed therapy and has the potential to

    improve the outcomes of the procedure.